Form4insider filings, from the source

SEC Form 4 · accession 0000899243-19-006452

Kaleido Biosciences, Inc. · KLDO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Noubar Afeyan
Director · 10% Owner
Cadena LLC
10% Owner
Period of report
Mar 4, 2019
Accepted (ET)
Mar 6, 2019 · 4:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001751299

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF4,F5Mar 4, 2019C665,908—A665,908ISee Footnote
Common StockF6,F1Mar 4, 2019C173,586—A216,451ISee Footnote
Common StockF6,F5Mar 4, 2019C281,203—A947,111ISee Footnote
Common StockF1holding———42,865ISee Footnote
Common StockF2holding———42,865ISee Footnote
Common StockF3holding———1,649,999ISee Footnote

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series A Preferred StockF4,F5—Mar 4, 2019C1,331,816D——Common Stock665,9080I
Series A-1 Preferred StockF6,F1—Mar 4, 2019C347,173D——Common Stock173,5860I
Series A-1 Preferred StockF6,F5—Mar 4, 2019C562,407D——Common Stock281,2030I

Explanation of responses

Remarks

Due to limitations of the electronic filing system, each of Flagship Ventures Fund V General Partner LLC, Flagship Ventures Fund V, L.P., Flagship VentureLabs V LLC, Flagship VentureLabs V Manager LLC, Flagship Pioneering, Inc., Nutritional Health Disruptive Innovation Fund, L.P., Nutritional Health Side Fund, L.P., Flagship Ventures Opportunities Fund I, L.P., Flagship Ventures Opportunities Fund I General Partner LLC and Noubar B. Afeyan, Ph.D. are filing a separate Form 4 with respect to securities of the Issuer.